EXAGEN INC. (XGN) - Form 8-K Summary
Business Context and Reporting Period
Exagen Inc. filed this Current Report on Form 8-K on March 10, 2026, to announce the release of its financial results for the quarter and fiscal year ended December 31, 2025. The company is incorporated in Delaware and trades on The Nasdaq Global Market under the symbol XGN.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the body of this Form 8-K. The report serves solely as a notification of the results announcement.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information furnished under Item 2.02, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2026) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance trends not detailed in this summary.
- Check for any updated financial guidance or operational outlook provided in the full press release.
- Confirm the status of the company's liquidity and debt obligations as reported in the full financial statements.